{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:20:13Z","timestamp":1776118813730,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217572","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T17:31:15Z","timestamp":1560360675000},"page":"e0217572","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients"],"prefix":"10.1371","volume":"14","author":[{"given":"Liad","family":"Hinden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Avner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polina","family":"Stepensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuven","family":"Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-612X","authenticated-orcid":true,"given":"Osnat","family":"Almogi-Hazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"ref1","first-page":"353","article-title":"Williams Hematology","author":"AR Rezvani","year":"2016"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2141.2012.09128.x","article-title":"Diagnosis and management of chronic graft-versus-host disease","volume":"158","author":"FL Dignan","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","article-title":"The biology of graft-versus-host disease: experimental systems instructing clinical practice","volume":"124","author":"KA Markey","year":"2014","journal-title":"Blood"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: biological insights from preclinical and clinical studies","volume":"129","author":"KP MacDonald","year":"2017","journal-title":"Blood"},{"key":"ref5","first-page":"217","article-title":"Haematopoietic stem cell transplantation","author":"J Apperly","year":"2012"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"HJ Deeg","year":"2007","journal-title":"Blood"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"AI Caplan","year":"1991","journal-title":"J Orthop Res"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"K Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/biomedicines5030039","article-title":"Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?","volume":"5","author":"N Dunavin","year":"2017","journal-title":"Biomedicines"},{"key":"ref10","article-title":"Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications","author":"ME Castro-Manrreza","year":"2015","journal-title":"J Immunol Res"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/bmt.2008.316","article-title":"Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium","volume":"43","author":"M von Bonin","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcmd.2007.06.021","article-title":"Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation","volume":"40","author":"I M\u00fcller","year":"2008","journal-title":"Blood. Cells Mol Dis"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1097\/TP.0000000000001029","article-title":"The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature","volume":"100","author":"JM Munneke","year":"2016","journal-title":"Transplantation"},{"issue":"3","key":"ref14","first-page":"225","article-title":"Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)","volume":"3","author":"IB Resnick","year":"2013","journal-title":"Am J Blood Res"},{"issue":"9624","key":"ref15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"K Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/icb.2012.62","article-title":"Cellular and molecular interactions of mesenchymal stem cells in innate immunity","volume":"91","author":"GM Spaggiari","year":"2013","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/stem.2026","article-title":"Ex Vivo Induced Regulatory Human\/Murine Mesenchymal Stem Cells as Immune Modulators","volume":"33","author":"L Hinden","year":"2015","journal-title":"Stem Cells"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbmt.2014.02.007","article-title":"Targeting the IL17 pathway for the prevention of graft-versus-host disease","volume":"20","author":"AB van der Waart","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"NJ Wilson","year":"2007","journal-title":"Nat Immunol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","article-title":"Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells","volume":"18","author":"M Najar","year":"2016","journal-title":"Cytotherapy"},{"issue":"3","key":"ref21","first-page":"170","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"M Saraiva","year":"2010"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: Biology, Design and Application","volume":"36","author":"N Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/leu.2011.384","article-title":"Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring","volume":"26","author":"E Dander","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/stem.1386","article-title":"Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation","volume":"31","author":"R Jitschin","year":"2013","journal-title":"Stem Cells"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/leu.2014.225","article-title":"Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10","volume":"29","author":"Y Peng","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/leu.2015.89","article-title":"Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells","volume":"29","author":"LC Te Boome","year":"2015","journal-title":"Leukemia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:43:07Z","timestamp":1588988587000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217572"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217572","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,12]]}}}